A pharmaceutical business cannot enter the UAE market with a general trading licence and a warehouse lease alone. The company, regulated facility, responsible professionals, foreign manufacturing site and each medical product may all require separate approvals. Importing, distribution and promotion also have different legal meanings.
Pharmaceutical company registration in the UAE now sits primarily under the Emirates Drug Establishment, or EDE, following the transfer of major regulatory services from the Ministry of Health and Prevention. A Dubai or other emirate-level economic authority still issues the commercial licence, while EDE controls relevant pharmaceutical facilities, product marketing authorisations, manufacturer registration, import and export permits, pricing and good-practice compliance.
The right route therefore depends on what the business will actually do: represent a manufacturer, import medicines, distribute locally, store products, re-export or manufacture. This guide explains the licensing layers, documents, process, published fees, timelines and compliance decisions that investors should settle before incorporation or premises fit-out.
What Pharmaceutical Company Registration in the UAE Involves
A compliant pharmaceutical setup normally requires several linked approvals rather than one pharmaceutical company licence.
| Approval layer | Main purpose | Typical authority |
|---|---|---|
| Commercial registration | Creates the UAE legal entity and approved economic activity | DET, another emirate’s economic department or a free-zone authority |
| Pharmaceutical facility licence | Authorises the regulated establishment and premises | Emirates Drug Establishment for warehouses, stores, factories and marketing offices |
| Professional licensing | Approves the pharmacist in charge and other regulated staff | MOHAP or the competent local health authority |
| Manufacturer and marketing-right registration | Establishes the regulated foreign or local product owner and manufacturing site | EDE |
| Product marketing authorisation | Approves each medicine or other medical product for UAE circulation | EDE |
| Import, export or re-export permit | Authorises regulated product movements and, where applicable, individual shipments | EDE and customs, with additional controls for restricted products |
Federal Decree-Law No. 38 of 2024 governs medical products, pharmacists and pharmaceutical establishments, including establishments in free zones. Consequently, a free-zone licence does not remove federal product or facility regulation.
Choose the Correct Pharmaceutical Business Activity
The business model determines the premises, staffing, inspections, ownership review and products the company may handle.
Marketing office
A marketing office represents a registered marketing-right holder, introduces products to healthcare professionals and monitors circulation. Its licence alone does not permit import, sale-stock storage or distribution; those functions need appropriately licensed establishments.
Medical warehouse, storage and distribution
A warehouse or related facility may receive approval for specified import, distribution, storage or re-export activities. Federal law distinguishes these functions, so the commercial activity and EDE licence must match.
The site needs temperature control, security, segregation, records, recall capability and a responsible professional. Medicine handling normally requires a full-time licensed pharmacist. A qualifying equipment-only facility may use a licensed biomedical engineer.
Import and distribution
An import licence does not cover every medicine. The facility, manufacturing site and product need relevant approvals, and EDE may require a shipment permit.
Under the 2024 law, a marketing-right holder generally appoints at least two EDE-licensed importers and one or more distributors. One main establishment manages product licensing, pharmacovigilance and the product lifecycle.
Pharmaceutical manufacturing
Manufacturing requires the most demanding approval path. It combines company incorporation, industrial and local approvals, EDE-approved engineering plans, utilities and environmental clearances, qualified staff, quality-control systems, inspections and Good Manufacturing Practice certification.
The manufacturer must define dosage forms, production lines, material and personnel flows, packaging, sterilisation where relevant, laboratory equipment and quality responsibilities before construction. Investors should obtain technical approval for the plans before committing to a final build.
Export and re-export
A UAE base may support regional export or re-export, but the business needs an approved activity and facility. Products moving through a free-zone logistics warehouse may require Good Storage and Distribution Practice certification, agreements with the marketing-right holder or manufacturer, EDE registrations and a licensed pharmacist responsible for the assigned storage area.
Mainland or Free Zone for a Pharmaceutical Company?
Mainland and free-zone structures can both work, but their usefulness depends on whether the company will sell in the UAE or operate mainly as a regional logistics and export hub.
A mainland entity is often more direct for importing, wholesaling and distributing medical products into the UAE market, subject to EDE licensing. In Dubai, the Department of Economy and Tourism handles the commercial licence, while municipality, Civil Defence and other authorities may approve the premises.
A free-zone company may suit manufacturing, research, regional headquarters, logistics or re-export. However, moving products from a free zone into the UAE mainland counts as a regulated import. The company still needs a compliant importer, product approval, customs process and any EDE permit.
Do not assume that ordinary foreign-ownership rules settle the structure. The 2024 pharmaceutical law leaves local national-contribution requirements for onshore facilities to the competent emirate-level corporate authority. EDE guidance allows non-citizen ownership where that local authority confirms the permitted percentage. Free-zone establishments may receive an exemption from a prescribed national-contribution percentage, but they remain subject to EDE licensing. Confirm the ownership position in writing before incorporation.
Pharmaceutical Company Registration Requirements in the UAE
Requirements vary by activity, but EDE facility approval normally combines owner due diligence, premises evidence, responsible staff and technical compliance.
Common corporate and premises documents include:
- Shareholder and manager passport and Emirates ID copies, where applicable
- Trade-name reservation and initial commercial approval
- Memorandum and articles of association
- Partner list and ownership approvals
- Lease agreement and municipality-approved land or location plan
- Architectural drawings from an approved engineering consultant
- Civil Defence preventive-safety certificate
- Site photographs and Tatmeen registration where required
- Feasibility study for a marketing office or manufacturing project
Technical documents may include:
- Responsible pharmacist’s professional licence and employment documents
- Site Master File and organisational chart
- Standard operating procedures and quality manual
- Temperature mapping, monitoring and cold-chain controls
- Security, quarantine, returns, recall and expired-stock procedures
- Product list and storage categories
- Good Storage and Distribution Practice evidence
- GMP plans and production documentation for manufacturers
EDE can request additional records based on product risk, controlled status, facility type and inspection findings.
How to Register a Pharmaceutical Company in the UAE
The sequence should protect the investor from leasing or constructing a site that cannot pass regulatory inspection.
1. Define the regulated activity
Specify whether the company will market, import, distribute, store, re-export or manufacture. Also classify the portfolio: conventional medicines, biologics, controlled products, supplements, healthcare products or medical devices can follow different technical routes.
2. Confirm jurisdiction and ownership
Select the emirate and mainland or free zone structure. Obtain confirmation that the proposed ownership, legal form and activity can receive the required pharmaceutical facility licence.
3. Reserve the name and seek preliminary approval
Reserve the trade name with the economic authority, prepare owner information and apply for the relevant EDE pre-licensing stage. Security and owner checks may form part of this process.
4. Select and approve the premises
Submit the lease, land plan and engineering layout. A warehouse must meet storage, safety, access and workflow requirements. A factory requires detailed plans showing personnel and material movement before construction.
5. Form the company and complete local approvals
Issue the commercial licence with the correct activities. Then complete municipality, planning, Civil Defence, utilities, customs and industrial approvals relevant to the project.
6. Appoint licensed technical personnel
Hire the responsible pharmacist and obtain professional approval. Manufacturers also need qualified leadership for production, quality assurance, quality control and pharmacovigilance functions.
7. Complete EDE inspection and facility licensing
Request initial or final inspection as applicable, correct any findings and pay the final licence fee. The business may operate only after EDE issues final approval, not merely after preliminary consent or commercial registration.
8. Register the manufacturer and marketing-right holder
A foreign manufacturing site usually submits a legalised manufacturing licence, valid GMP certificate, Site Master File, product list and authorisation documents. EDE registration must precede product marketing-authorisation applications.
9. Obtain product marketing authorisation
Submit a separate dossier for each product, including quality, safety and efficacy information, certificates from the country of origin, stability data, bioequivalence where required, pharmacovigilance documentation, labelling and pricing material.
10. Arrange imports and market release
Complete customs registration, importer and distributor appointments, Tatmeen requirements and shipment permits. Certain biological, controlled or high-risk products may need added batch-release, custody, security or import approvals.
Pharmaceutical Product Registration in the UAE
Company registration and product registration are separate. A valid warehouse or marketing office does not allow an unapproved medicine to circulate.
EDE requires the marketing-right holder and relevant manufacturing sites to be registered before the product application. The applicant for a conventional drug or biopharmaceutical marketing authorisation must generally be an EDE-licensed medical warehouse, local manufacturer or marketing office.
A typical foreign-manufacturer file may include:
- Legalised authorisation appointing the UAE applicant
- Manufacturing licence and current GMP certificate
- Certificate of Pharmaceutical Product or free-sale evidence
- Site Master File and manufacturing-site information
- Full quality, safety and efficacy dossier
- Stability and bioequivalence data where applicable
- Packaging, labelling and patient information
- Pharmacovigilance plan and UAE responsible person
- Product samples and laboratory-analysis requirements
- Pricing submission and agency or importer arrangements
EDE currently publishes a 45-working-day service duration for conventional drug and biopharmaceutical marketing authorisation. That period assumes a complete application and does not necessarily include the time needed for manufacturer registration, deficiency responses, laboratory work, pricing decisions or document legalisation. Product certificates are generally valid for five years or the period granted by EDE.
Pharmaceutical Company Licence Cost in the UAE
A UAE pharmaceutical company licence typically costs AED 10,000–50,000+, depending on emirate, licence type, approvals, premises, and regulatory requirements; additional registration and compliance fees may apply. The total cost combines commercial incorporation, regulated facility licensing, premises, staff, quality systems and product approvals.
Published EDE fee examples include:
| EDE service | Published fee example |
|---|---|
| Facility application | AED 100 |
| Initial or final inspection for warehouse or marketing office | AED 1,000 per inspection |
| Medical warehouse final licence | AED 7,500 |
| Marketing office final licence | AED 10,000 |
| Export warehouse final licence | AED 10,000 |
| Factory plan approval | AED 2,000 |
| Factory final inspection | AED 3,000 per inspection |
| Pharmaceutical or medical-product factory final licence | AED 50,000 |
| Medical-product manufacturer registration | AED 10,000 plus application fee |
| Conventional medicine marketing authorisation | AED 7,000 plus application fee |
| Product analysis or re-analysis | AED 3,500 |
| Pharmacovigilance-plan evaluation | AED 1,000 |
| Pricing certificate after approval | AED 500 |
These are regulator fees published for specific services, not a complete setup quotation. Economic-licence fees, lease, fit-out, cold rooms, monitoring systems, validation, Civil Defence work, customs, pharmacist salaries, visas, legalisation, consulting, laboratory tests and each additional product create further cost. Fees can change, so applicants should verify the live EDE schedule and local-authority charges.
How Long Does Pharmaceutical Company Formation Take?
A simple commercial entity can form quickly, but end-to-end pharmaceutical approval normally takes longer because premises, staff and products undergo separate reviews.
EDE indicates that it can issue a final facility licence within three working days after receiving the last completed requirement and fee. That figure does not include site selection, drawings, construction, professional licensing, inspections or correction of findings.
A marketing office may therefore progress faster than a medical warehouse. A warehouse with validated cold storage takes longer, while a pharmaceutical factory can require an extended design, construction, qualification and GMP programme. Product registration runs on its own timeline and should not be confused with facility licensing.
Ongoing Pharmaceutical Company Compliance
Approval creates continuing responsibilities for product quality, availability, traceability and safety.
A compliant operation may need to maintain:
- Valid commercial, facility and professional licences
- GMP or storage and distribution standards
- Temperature, humidity and cold-chain records
- Tatmeen traceability and inventory controls
- Approved prices, labels and promotional materials
- Pharmacovigilance reporting and a UAE responsible person
- Complaint, adverse-event, recall and shortage procedures
- Import, export and re-export permits
- Controlled-product custody and stock records
- Approved disposal of expired or damaged medical products
- Supplier, customer and authorised-channel verification
Federal law prohibits circulation without marketing approval and allows inspections, recalls, suspension and other enforcement measures. Advertising also requires the appropriate approval; product registration does not authorise every promotional claim.
Common Pharmaceutical Setup Mistakes
Most delays arise when the commercial structure is chosen before the regulated operating model.
- Using a general trading activity instead of the correct pharmaceutical activity
- Signing a long lease before EDE reviews the site or drawings
- Assuming a free-zone licence permits UAE mainland distribution
- Treating company incorporation as product registration
- Appointing technical staff too late
- Importing before the manufacturer, product and shipment route are approved
- Underestimating cold-chain validation and backup-power requirements
- Failing to confirm foreign-ownership conditions with the local authority
- Using one exclusive importer despite the newer multi-importer framework
- Marketing a product before advertisement approval
A regulatory map prepared before incorporation should show every entity, facility, professional, product and shipment approval required for the intended supply chain.
Conclusion: Planning a Pharmaceutical Business Setup in the UAE
Pharmaceutical company registration in the UAE requires commercial and regulatory approvals to work together. The key decision is not simply mainland versus free zone, but whether the company will promote, import, distribute, store, re-export or manufacture medical products.
Investors should confirm ownership, activity and premises with the relevant authorities before incorporation or fit-out. They should then sequence the commercial licence, EDE facility approval, technical staffing, manufacturer registration, product marketing authorisation and import permissions. BizInvestFirm can assist with the UAE company-formation and local-licensing coordination, while specialised pharmaceutical regulatory professionals handle technical dossiers, quality systems and EDE submissions.
Frequently Asked Questions
These answers address common questions about pharmaceutical business setup in the UAE.
Who regulates pharmaceutical company registration in the UAE?
The Emirates Drug Establishment regulates relevant factories, warehouses, medical stores, marketing offices, products, manufacturer registrations and import or export permits. Economic authorities issue commercial licences, while MOHAP or local health authorities license relevant professionals and certain pharmacy activities.
Can a foreign investor own a pharmaceutical company in the UAE?
Potentially, but ownership depends on the activity, emirate and local authority approval. Do not assume 100% mainland ownership. Obtain written confirmation before forming the company.
Is a general trading licence enough to sell medicines?
No. The business needs the correct commercial activity, an EDE-licensed pharmaceutical facility, authorised products, qualified staff and relevant import or distribution permissions.
Can a free-zone pharmaceutical company sell in the UAE mainland?
Not automatically. Mainland circulation requires an eligible importer or distributor, EDE product and facility approvals, customs clearance and compliance with the federal pharmaceutical framework.
Does every pharmaceutical product need UAE registration?
Medical products generally require EDE marketing authorisation before circulation unless a specific legal exemption applies. Manufacturer and marketing-right registrations usually come first.
How much does a pharmaceutical company licence cost in the UAE?
EDE’s published final licence fee is AED 7,500 for a medical warehouse, AED 10,000 for a marketing office and AED 50,000 for a factory. Inspections, commercial licensing, premises, staff and product registrations are additional.
How long does pharmaceutical product registration take?
EDE publishes 45 working days for conventional drug or biopharmaceutical marketing authorisation. Incomplete dossiers, testing, pricing, legalisation and deficiency responses can extend the overall timeline.
Does a pharmaceutical warehouse need a pharmacist?
A medicine-handling warehouse normally requires a full-time licensed responsible pharmacist. A facility limited to eligible medical equipment may use an approved biomedical engineer where regulations allow.
